Friday, November 20, 2020: 9:30 AM
Pharmaceutical Discovery, Development and Manufacturing Forum (26) (vFairs Auditorium)
QbD is based on a fundamental understanding of process performance and product quality, which can be derived from first principles modeling methods. Model development and use routinely suffers from peer-to-peer variability that undermines the credibility of model-based evidence. In this talk we discuss Amgen’s approach to model quality and modeling lifecycle management to enable model-informed decisions and promote model-based filing activities. Several case studies will be presented.
See more of this Session: PD2M Panel Discussion Part 1- QbD based Filing: Realizing the Promise (Invited Talks)
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum